Citadel Advisors
SMTI icon

Citadel Advisors’s Sanara MedTech SMTI Stock Holding History

Citadel Advisors’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$868K Buy
36,813
+5,700
+18% +$118K ﹤0.01% 8564
2026
Q1 		$535K Buy
31,113
+20,965
+207% +$431K ﹤0.01% 9138
2025
Q4 		$237K Sell
10,148
-8,906
-47% -$230K ﹤0.01% 10677
2025
Q3 		$605K Sell
19,054
-3,719
-16% -$112K ﹤0.01% 8665
2025
Q2 		$647K Buy
22,773
+7,350
+48% +$220K ﹤0.01% 8021
2025
Q1 		$476K Sell
15,423
-6,561
-30% -$223K ﹤0.01% 8582
2024
Q4 		$730K Buy
21,984
+1,491
+7% +$50.6K ﹤0.01% 7716
2024
Q3 		$620K Buy
+20,493
New +$639K ﹤0.01% 7808
2024
Q2 		– Sell
-8,038
Closed -$297K – 15307
2024
Q1 		$297K Sell
8,038
-2,574
-24% -$96.2K ﹤0.01% 9467
2023
Q4 		$436K Buy
10,612
+943
+10% +$30.3K ﹤0.01% 8401
2023
Q3 		$301K Sell
9,669
-8,244
-46% -$319K ﹤0.01% 9164
2023
Q2 		$718K Sell
17,913
-235
-1% -$9.61K ﹤0.01% 7136
2023
Q1 		$749K Buy
18,148
+5,578
+44% +$235K ﹤0.01% 7414
2022
Q4 		$572K Sell
12,570
-2,262
-15% -$77.9K ﹤0.01% 7967
2022
Q3 		$440K Buy
14,832
+3,878
+35% +$109K ﹤0.01% 8744
2022
Q2 		$229K Buy
+10,954
New +$256K ﹤0.01% 10415
2021
Q4 		– Sell
-5,997
Closed -$204K – 14687
2021
Q3 		$204K Buy
+5,997
New +$215K ﹤0.01% 11951

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Citadel Advisors's SMTI Position: Q2 2026 in Review

Citadel Advisors increased its Sanara MedTech (SMTI) stake by 18% in Q2 2026, buying an estimated $118K and bringing the position to 36,813 shares worth $868K. The position accounts for ﹤0.01% of the portfolio, ranked #8564.

Citadel Advisors first reported a position in SMTI in Q3 2021 and has held it in 17 quarters since. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Citadel Advisors held 36,813 shares of Sanara MedTech worth $868K as of Q2 2026.
  • Citadel Advisors bought 5,700 Sanara MedTech shares in Q2 2026, an estimated $118K.
  • Sanara MedTech made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8564 holding.
  • Citadel Advisors first reported a position in Sanara MedTech in Q3 2021 and has held it in 17 quarters since.
  • 74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.